151 related articles for article (PubMed ID: 38150037)
1. Systematic review and cumulative analysis of clinical properties of BRAF V600E mutations in PLNTY histological samples.
Baumgartner ME; Lang SS; Tucker AM; Madsen PJ; Storm PB; Kennedy BC
Childs Nerv Syst; 2024 May; 40(5):1361-1366. PubMed ID: 38150037
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of molecular subgroups of polymorphous low-grade neuroepithelial tumor of the young (PLNTY): A small single institutional case series and integrated analysis.
Vuong HG; Alzayadneh E; Reith TP; Eschbacher KL
Pathol Res Pract; 2023 Dec; 252():154922. PubMed ID: 37984047
[TBL] [Abstract][Full Text] [Related]
3. BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young.
Tateishi K; Ikegaya N; Udaka N; Sasame J; Hayashi T; Miyake Y; Okabe T; Minamimoto R; Murata H; Utsunomiya D; Yamanaka S; Yamamoto T
Acta Neuropathol Commun; 2020 Aug; 8(1):139. PubMed ID: 32811569
[TBL] [Abstract][Full Text] [Related]
4. Polymorphous low-grade neuroepithelial tumor of the young: case report and review focus on the radiological features and genetic alterations.
Chen Y; Tian T; Guo X; Zhang F; Fan M; Jin H; Liu D
BMC Neurol; 2020 Apr; 20(1):123. PubMed ID: 32252664
[TBL] [Abstract][Full Text] [Related]
5. A newly diagnosed case of polymorphous low-grade neuroepithelial tumor of the young.
Bitar M; Danish SF; Rosenblum MK
Clin Neuropathol; 2018; 37(4):178-181. PubMed ID: 29701169
[TBL] [Abstract][Full Text] [Related]
6. Pediatric and elderly polymorphous low-grade neuroepithelial tumor of the young: Typical and unusual case reports and literature review.
Furuta T; Moritsubo M; Muta H; Shimamoto H; Ohshima K; Sugita Y
Neuropathology; 2023 Aug; 43(4):319-325. PubMed ID: 36545913
[TBL] [Abstract][Full Text] [Related]
7. Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation.
Ida CM; Johnson DR; Nair AA; Davila J; Kollmeyer TM; Minn K; Fadra NM; Balcom JR; Fung KA; Kim DK; Kaufmann TJ; Kipp BR; Halling KC; Jenkins RB; Giannini C
J Neuropathol Exp Neurol; 2021 Sep; 80(9):821-829. PubMed ID: 34363682
[TBL] [Abstract][Full Text] [Related]
8. Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway.
Huse JT; Snuderl M; Jones DT; Brathwaite CD; Altman N; Lavi E; Saffery R; Sexton-Oates A; Blumcke I; Capper D; Karajannis MA; Benayed R; Chavez L; Thomas C; Serrano J; Borsu L; Ladanyi M; Rosenblum MK
Acta Neuropathol; 2017 Mar; 133(3):417-429. PubMed ID: 27812792
[TBL] [Abstract][Full Text] [Related]
9. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
[No Abstract] [Full Text] [Related]
10. [Clinicopathological features of polymorphous low-grade neuroepithelial tumor of the young].
Zhao S; Wang J; Li MN; Ding Y; Pan MH; Song K
Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):640-646. PubMed ID: 35785835
[No Abstract] [Full Text] [Related]
11. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
12. Genomic Analysis of Dysembryoplastic Neuroepithelial Tumor Spectrum Reveals a Diversity of Molecular Alterations Dysregulating the MAPK and PI3K/mTOR Pathways.
Surrey LF; Jain P; Zhang B; Straka J; Zhao X; Harding BN; Resnick AC; Storm PB; Buccoliero AM; Genitori L; Li MM; Waanders AJ; Santi M
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1100-1111. PubMed ID: 31617914
[TBL] [Abstract][Full Text] [Related]
13. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
[TBL] [Abstract][Full Text] [Related]
14. Neuroradiological features of the polymorphous low-grade neuroepithelial tumor of the young: five new cases with a systematic review of the literature.
Kurokawa M; Kurokawa R; Capizzano AA; Baba A; Ota Y; Pinarbasi E; Johnson T; Srinivasan A; Moritani T
Neuroradiology; 2022 Jun; 64(6):1255-1264. PubMed ID: 35001164
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis.
Xing H; Song Y; Zhang Z; Koch PD
J Mol Neurosci; 2021 Sep; 71(9):1815-1824. PubMed ID: 33791912
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional features of low-grade neuroepithelial tumors with the BRAF V600E mutation associated with epileptogenicity.
Iijima K; Komatsu K; Miyashita S; Suyama K; Murayama K; Hashizume K; Tabe NK; Miyata H; Iwasaki M; Taya S; Hoshino M
Genes Cells; 2024 Mar; 29(3):192-206. PubMed ID: 38269481
[TBL] [Abstract][Full Text] [Related]
17. Radiological and surgical aspects of polymorphous low-grade neuroepithelial tumor of the young (PLNTY).
Armocida D; Berra LV; Frati A; Santoro A
Acta Neurol Belg; 2023 Apr; 123(2):327-340. PubMed ID: 36894761
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological features of polymorphous low-grade neuroepithelial tumor of the young].
Ge R; Fang HF; Chang YQ; Li Z; Liu CF
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1131-1135. PubMed ID: 33152817
[No Abstract] [Full Text] [Related]
19. Clinical, Radiological, Pathological Features and Seizure Outcome With Surgical Management of Polymorphous Low-Grade Neuroepithelial Tumor of the Young Associated With Epilepsy.
Fei X; Zhao J; Wei W; Wang W; Kong X; Qian R; Niu C; Yao Y
Front Oncol; 2022; 12():863373. PubMed ID: 35372027
[TBL] [Abstract][Full Text] [Related]
20. Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.
Pagès M; Beccaria K; Boddaert N; Saffroy R; Besnard A; Castel D; Fina F; Barets D; Barret E; Lacroix L; Bielle F; Andreiuolo F; Tauziède-Espariat A; Figarella-Branger D; Puget S; Grill J; Chrétien F; Varlet P
Brain Pathol; 2018 Jan; 28(1):103-111. PubMed ID: 27984673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
